Spots Global Cancer Trial Database for Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
Official Title: Community-based Early Stage Lung Cancer Screening With Low-dose Computed Tomography in China
Study ID: NCT02898441
Conditions
Interventions
Study Description
Brief Summary: The present study is a randomized controlled trial of LDCT screening for lung cancer versus usual care. 6000 high-risk subjects (age 45-70) were recruited and randomized to the Active arm (Baseline + 2 biennial repeated LDCT screening) or to the Passive arm, followed up in usual care (Baseline + 2 biennial repeated questionnaire inquiries). Follow-up for lung cancer incidence, lung cancer mortality and overall mortality was performed. Blood samples were stored from the Active arm in a Biobank. Management of positive screening test was carried out by a pre-specified protocol.
Detailed Description:
Eligibility
Minimum Age: 45 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Shanghai Chest hospital, Shanghai, Shanghai, China
Contact Details
Name: Baohui Han, MD, PhD
Affiliation: Shanghai Chest Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
